Pharma & Biotech
Acasti Pharma edging closer to commercializing CaPre as it eyes topline clinical data for Christmas
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
Kazia Therapeutics to share pipeline results with market and clinicians
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.